Shuren Steps Down As US FDA Device Center Director

Shuren is retiring after 15 years as head of the FDA Center for Devices and Radiological Health.

CDRH Director Jeff Shuren in his office
Shuren will leave the federal government after 28 years of service. • Source: Ferdous Al-Faruque

Jeff Shuren, the longtime director of the US Food and Drug Administration’s Center for Devices and Radiological Health, plans to retire at the end of the month after 15 years in the position, he announced 23 July.

More from US FDA

Pink Sheet Podcast: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?

Pink Sheet reporter and editors discuss FDA Commissioner Martin Makary’s decision to have one of his assistants lead negotiations for Novavax’s delayed COVID-19 vaccine review, as well as some recent missed review deadlines, which may be the result of recent FDA cuts.

How Tumult At US FDA Could Impact Merger and Acquisition Strategy

 

With review and development uncertainly increasing, "it’s going to take longer for certain targets … to progress to a place where they’ve been derisked enough that big pharma is ready to write a big check," said Andrew Goodman of Paul Hastings.

US FDA Not Industry’s ‘Sock Puppet,’ Ultragenyx’s Emil Kakkis Says

 
• By 

The biotech CEO said the Trump Administration’s treatment of FDA employees, including the HHS secretary’s comments about industry capture, are insulting to agency staff, but he is encouraged by FDA Commissioner Martin Makary’s talk of a new conditional approval pathway.

US FDA Commissioner’s Office Plans Involvement In Many Approvals In Potential Major Change

 

FDA Commissioner Martin Makary's remarks that his special assistant Tracy Beth Høeg will "be involved in other approval procedures" besides Novavax's COVID-19 vaccine application could be a dramatic change in operations, potentially making the approval system unpredictable.

More from Agency Leadership